Combination products with tyrosine kinase inhibitors and their use

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Tiedt, Ralph,Chatenay-Rivauday, Christian,Ito, Moriko,Peng, Bin,Gong, Ying,Akimov, Mikhail

申请号：

AU2016203741

公开号：

AU2016203741A1

申请日:

2016.06.03

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016203741A120160623.pdf#####H: dar Intrwovn NRPortbI DCC DAR I0262416I.docx-3/06/2016 ABSTRACT The present invention relates to pharmaceutical products comprising a combination of (i) a MET inhibitor and (ii) an EGFR inhibitor, or a pharmaceutically acceptable salt thereof, respectively, or a prodrug thereof, which are jointly active in the treatment of proliferative diseases, corresponding pharmaceutical formulations, uses, methods, processes, commercial packages and related invention embodiments.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/